Calcitonin gene-related peptide in the cardiovascular system: Characterization of receptor populations and their (patho)physiological significance

Pharmacological Reviews

Volumn 48, Issue 2, 1996, Pages 253-288

  Bell, David ^a   Mcdermott, Barbara J ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; CALCITONIN GENE RELATED PEPTIDE RECEPTOR;

ARTICLE; CARDIOVASCULAR DISEASE; CHRONOTROPISM; CLUSTER HEADACHE; DRUG EFFECT; DRUG MECHANISM; DRUG SCREENING; HEART ELECTROPHYSIOLOGY; HUMAN; INOTROPISM; NONHUMAN; PATHOPHYSIOLOGY; PEPTIDE ANALYSIS; PRIORITY JOURNAL; RAYNAUD PHENOMENON; SUBARACHNOID HEMORRHAGE;

AMINO ACID SEQUENCE; ANIMALS; BINDING, COMPETITIVE; CALCITONIN GENE-RELATED PEPTIDE; CAPSAICIN; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; HUMANS; MOLECULAR SEQUENCE DATA; RECEPTORS, CALCITONIN GENE-RELATED PEPTIDE; SEQUENCE ALIGNMENT; SYNAPTIC TRANSMISSION; TISSUE DISTRIBUTION;

EID: 0029977182     PISSN: 00316997     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (336)

1. AIYAR, N., NAMBI, P., GRIFFIN, E., BHATNAGAR, P. AND FEURERSTEIN, G.: Identification and characterisation of CGRP receptors in porcine renal medullary membranes. Endocrinology 129: 965-969, 1991.
2. ALEVIZAKI, M., SHIRAISHI, A., RASSOOL, F. V., FERRIER, G. J. M., MACINTYRE, I., AND LEGON, S.: The calcitonin-like sequence of the β-CGRP gene. FEBS Lett. 206: 47-52, 1986.
3. AMARA, S. G., ARRIZZA, J. L., LEEF, S. E., SWANSON, L. W., EVANS, R. M., AND ROSENFELD, M. G.: Expression in the brain of a messenger-RNA encoding a novel neuropeptide homologous to CGRP. Science (Wash. DC) 229: 1094-1097, 1985.
4. AMARA, S. G., EVANS, R. M., AND ROSENFELD, M. G.: Calcitonin/CGRP transcription unit: tissue-specific expression involves selective use of alternative polyadenylation sites. Mol. Cell. Biol. 4: 2151-2160, 1984.
5. AMERINI, S., MANTELLI, L., FILIPPI, S., AND LEDDA, F.: Effects of aging and hypertension on vasorelaxant activity of CGRP: a comparison with other vasodilator agents. J. Cardiovasc. Pharmacol. 23: 432-437, 1994.
6. AMERINI, S., MANTELLI, L., AND LEDDA, F.: NO is not involved in the effects of NANC stimulation in rat mesenteric vascular bed. Neuropeptides 25: 51-56, 1993.
7. ANAND, I. S., GURDEN, J., WANDER, G. S., O'GARA, P., HARDING, S. E., FERRARI, R., CORNACCHIARI, A., WAHL, P. L., AND POOLE-WILSON, P. A.: Cardiovascular and hormonal effects of CGRP in congestive heart failure. J. Am. Coll. Cardiol. 17: 208-217, 1991.
8. ARDEN, W. A., FISCUS, R. R., WANG, X., YANG, L., MALEY, R., NIELSON, M., LANZO, S., AND GROSS, D. R.: Elevations in circulating CGRP correlate with haemodynamic deterioration during endotoxic shock in pigs. Circ. Shock. 42: 147-153, 1994.
9. BEAUMONT, K., MOORE, C. X., PITTNER, R., WOLFE-LOPEZ, D., PRICKETT, K., YOUNG, A. A., RINK, T. J.: Regulation of muscle glycogen metabolism by CGRP and amylin: CGRP receptors are not involved. Br. J. Pharmacol. 115: 713-715, 1995.
10. BELL, D., AND MCDERMOTT, B. J.: CGRP stimulates a positive contractile response in rat ventricular cardiomyocytes. J. Cardiovasc. Pharmacol. 23: 1011-1021, 1994a.
11. BELL, D., AND MCDERMOTT, B. J.: Use of the cyclic AMP antagonist, Rp-cAMPS, to distinguish between cyclic A. M. P.-dependent and cyclic AMP-independent contractile responses in rat ventricular cardiomyocytes. J. Mol. Cell. Cardiol. 26: 1439-1448, 1994b.
12. BELL, D., AND MCDERMOTT, B. J.: Inhibition by verapamil and diltiazem of agonist stimulated contractile responses in mammalian ventricular cardiomyocytes. J. Mol. Cell. Cardiol. 27: 1977-1987, 1995a.
13. BELL, D., AND MCDERMOTT, B. J.: Activity of amylin at CGRP-1 receptors coupled to positive contractile response in rat ventricular cardiomyocytes. Regul. Pept., 60: 125-133, 1995b.
14. BELL, D., SCHLUTER, K. D., ZHOU, X. J., MCDERMOTT, B. J., AND PIPER, H. M.: Hypertrophic effects of CGRP and amylin on adult ventricular cardiomyocytes. J. Mol. Cell. Cardiol. 27: 2433-2443, 1995.
15. BENY, J. L., BRUNET, P. C., AND HUGGEL, H.: Effects of Substance P, CGRP and capsaicin on tension and membrane potential of pig coronary artery in vitro. Regul. Pept. 25: 25-36, 1989.
16. BOYLE, J. J., AND BROWN, M. J.: Glibenclamide fails to reverse relaxations induced by CGRP in human mammary artery and saphenous vein. (Abstract) Br. J. Pharmacol. 102: 200P, 1991.
17. BRAIN, S. D., HUGHES, S. R., CAMBRIDGE, H., AND O'DRISCOLL, G.: The contribution of CGRP to neurogenic vasodilator responses. Agents Actions 38: C19-C21, 1993.
18. BRAIN, S. D., MACINTYRE, I., AND WILLIAMS, T. J.: A second form of hCGRP which is a potent vasodilator. Eur. J. Pharmacol. 124: 349-352, 1986.
19. BRAIN, S. D., WILLIAMS, T. J., TIPPENS, J. R., MORRIS, H. R., AND MACINTYRE, I.: CGRP is a potent vasodilator. Nature (Lond.) 313: 54-56, 1985.
20. BRAIN, S. D., WIMALAWANSA, S. J., MACINTYRE, I., AND WILLIAMS, T. J.: The demonstration of vasodilator activity of pancreatic amylin amide in the rabbit. Am. J. Pathol., 136: 487-490, 1990.
21. BRATVEIT, M., HAUGAN, A., AND HELLE, K. B.: Effects of CGRP on regional haemodynamics and on selected hepato-splanchnic arteries from the rat: a comparison with VIP and atriopeptin II. Scand. J. Clin. Lab. Invest., 51: 167-174, 1991.
22. BREEZE, A. L., HARVEY, T. S., BAZZO, R., AND CAMPBELL, I. D.: Solution structure of hCGRP by H-NMR and distance geometry with restrained molecular dynamics. Biochemistry 30: 575-582, 1991.
23. BREIMER, L. H., MACINTYRE, I., AND ZAIDI, M.: Peptides from the calcitonin genes: molecular genetics, structure and function. Biochem. J. 255: 377-390, 1988.
24. BRETHERTON-WATT, D., GHATEI, M. A., BLOOM, S. E., WILLIAMS, S., AND BLOOM, S. R.: Islet amyloid polypeptide-like immunoreactivity in human tissue and endocrine tumours. J. Clin. Endocrinol. Metab. 76: 1072-1074, 1993.
25. BUNKER, C. B., REAYLEY, C., O'SHAUGHNESSY, D. J., AND DOWD, P. M.: CGRP in treatment of severe peripheral vascular insufficiency in Raynaud's phenomenon. Lancet 342: 80-83, 1993.
26. BUNKER, C. B., TERENGHI, G., SPRINGALL, D. R., POLAK, J. M., AND DOWD, P. M.: Deficiency of CGRP in Raynaud's phenomenon. Lancet 336: 1530-1533, 1990.
27. BUTLER, A., BEATTIE, D. T., AND CONNOR, H. E.: Human α- and β-CGRP-mediated responses in vitro: sensitivity to the CGRP receptor antagonist CGRP8-37. Br. J. Pharmacol. 110: 151P (Abstract), 1993.
28. CARTER, T. L., PARK, P., PRATT, K., MAGNO, M., AND MANNION, J. D.: Effects of CGRP on the migration of endothelial cells of human origin. FASEB J. 7: 125 (Abstract), 1993.
29. 1 receptor mediates vasodilation in the rat isolated and perfused kidney. Life Sci. 53: 153-158, 1993.
30. 8-37: role of CGRP in internal anal sphincter relaxation. J. Pharmacol. Exper. Ther. 256: 1019-1024, 1990.
31. CHANTRY, A., LEIGHTON, B., AND DAY, A. J.: Cross-reactivity of amylin with CGRP-binding sites in rat liver and skeletal muscle membranes. Biochem. J. 277: 139-143, 1991.
32. CHARO, I. F., SHAK, S., KARASEK, M. A., DAVISON, P. M., AND GOLDSTEIN, I. M.: Prostacyclin is not a major metabolite of arachidonic acid in cultured endothelial cells from human microvessels. J. Clin. Invest. 74: 914-919, 1985.
33. CHATTERJEE, T. K., AND FISCHER, R. A.: Multiple forms of the CGRP receptor in rat cerebellum. Mol. Pharmacol. 39: 798-804, 1991.
34. CHATTERJEE, T. K., MOY, J. A., AND FISCHER, R. A.: Characterisation and regulation of high affinity CGRP receptors in cultured neonatal rat cardiac myocytes. Endocrinology 128: 2731-2738, 1991.
35. CHEN, R. Y. Z., AND GUTH, P. H.: Interaction of endogenous nitric oxide and CGRP in sensory neuron-induced gastric vasodilation. Am. J. Physiol. 268: G791-C796, 1995.
36. 8-37. Am. J. Physiol. 256: E331-E335, 1989.
37. 1 receptors. J. Pharmacol. Exper. Ther. 269: 989-992, 1994.
38. COLLYEAR, K., GIRGIS, S. I., SAUNDERS, G., MACINTYRE, I., AND HOLT, G.: Predicted structure of the bovine CGRP and the carboxy-terminal flanking peptide of bovine CT precursor. J. Mol. Endocrinol. 6: 147-152, 1991.
39. COOPER, C. W., BOROSKYSA, S. A., AND PENG, T. C.: Secretion of CGRP from baby rat thyroid glands in vitro. Proc. Soc. Exp. Biol. Med. 180: 562-566, 1985.
40. COOPER, G. J. S.: Amylin compared to CGRP: structure, biology and relevance to metabolic disease. Endocrine Rev. 15: 163-201, 1994.
41. COOPER, G. J. S., DAY, A. J., WILLIS, A. C., ROBERTS, A. N., REID, K. B. M., AND LEIGHTON, B.: Amylin and the amylin gene-structure, function and relationship to islet amyloid and to diabetes mellitus. Biochem. Biophys. Acta 1014: 247-258, 1989.
42. COOPER, G. J. S., LEIGHTON, B., DIMITRIADIS, G. D., PARRYBILLINGS, M., KOWALCHUK, J. M., HOWLAND, K., WILLIS, A. C., AND REID, K. B. M.: Amylin found in amyloid deposits of human type 2 diabetes mellitus may be a hormone that regulates glycogen metabolism in skeletal muscle. Proc. Natl. Acad. Sci. USA 85: 7763-7766, 1988.
43. COOPER, G. J. S., WILLIS, A. C., CLARK, A., TURNER, R. C., SIM, R. B., AND REID, K. B. M.: Purification and characterization of a peptide from amyloid-rich pancreases of Type 2 Diabetic patients. Proc Natl Acad Sci USA 84: 8628-8632, 1987.
44. COUPE, M. O., MAK, J. C. W., YACOUB, M., OLDERSHAW, P. J., AND BARNES, P. J.: Autoradiographic mapping of CGRP receptors in human and guinea pig hearts. Circulation 81: 741-747, 1990.
45. CROSSMAN, D., MCEWAN, J., MCDERMOTT, J., MACINTYRE, I., AND DOLLERY, C. T.: hCGRP activates adenylate cyclase and releases prostacyclin from human umbilical vein endothelial cells. Br. J. Pharmacol. 92: 695-701, 1987.
46. DALSGAARD, C. J., JERNBECK, J., AND STAINS, W.: CGRP-like immunoreactivity in nerve fibers in human skin. Histochem. 91: 35-38, 1989.
47. DENNIS, T., FOURNIER, A., CADIEAUX, A., POMERLAU, F., JOLICOEUR, F. B., ST. PIERRE, S., AND QUIRION, R.: hCGRP8-37: a CGRP antagonist revealing CGRP receptor heterogeneity in the brain and periphery. J. Pharmacol. Exper. Ther. 254: 123-128, 1990.
48. DENNIS, T., FOURNIER, A., GUARD, S., ST. PIERRE, S., AND QUIRION, R.: CGRP binding sites in the nucleus accumbens: atypical structural requirements and marked phylogenic differences. Brain Res. 539: 59-66, 1991.
49. DENNIS, T., FOURNIER, A., ST. PIERRE, S., AND QUIRION, R.: Structure-activity profile of CGRP in peripheral and brain tissues: evidence for receptor multiplicity. J. Pharmacol. Exper. Ther. 251: 718-725, 1989.
50. DEWITT, B. J., CHENG, D. Y., CAMINIH, G. N., NOSSAMAN, B. D., COY, D. H., MURPHY, W. A., AND KADOWITZ, P. J.: Adrenomedullin exerts a vasodilator effect in the pulmonary vascular beds of cats in vivo. Eur. J. Pharmacol. 257: 303-306, 1994.
51. DI-PETTE, D. J., SCHWARZENBERGER, K., KERR, N., AND HOLLAND, O. B.: Dose-dependent systemic and regional haemodynamic effects of CGRP. Am. J. Med. Sci. 297: 65-70, 1989.
52. 1 receptor subtype in the vascular system of the rat: studies with hCGRP fragments and analogues. Peptides 11: 885-889, 1990.
53. DU X. Y., SCHOEMAKER, R. G., BOS, E., AND SAXENA, R. R.: Different pharmacological responses of atrium and ventricle: studies with human cardiac tissue. Eur. J. Pharmacol. 259: 173-180, 1994.
54. EASTON, A. S., AND FRASER, P. A.: CGRP reduces leaky cerebral venular permeability in the anaesthetised rat. J. Physiol. (Lond.) 459: 361P (Abstract), 1993.
55. EDBROOKE, M. R., PARKER, D., AND MCVEY, J. H.: Expression of the human CT/CGRP gene in lung and thyroid carcinoma. EMBO J. 4: 715-724, 1985.
56. EDVINSSON, L., EKMAN, R., AND HEDNER, P.: Congestive heart failure: involvement of perivascular peptides reflecting activity in sympathetic, parasympathetic and afferent nerves. Eur. J. Clin. Invest. 20: 85-89, 1990.
57. EDVINSSON, L., EKMAN, R., AND THULIN, T.: Reduced levels of CGRP but not substance P during and after treatment of severe hypertension in man. J. Hum. Hypertens. 3: 267-270, 1989a.
58. EDVINSSON, L., EKMAN, R., AND THULIN, T.: Circulating perivascular dilatory neuropeptides in hypertension. J. Hypertens. 7: 5194-5195, 1989b.
59. EDVINSSON, L., FREDHOLM, B. B., HAMEL, E., JANSEN, I., AND VERRECHIA, C.: Perivascular peptides relax arteries concomitant with stimulation of cyclic AMP accumulation or release of an endothelium derived relaxing factor. Neurosci. Lett. 58: 213-220, 1985a.
60. EDVINSSON, L., GULBENKIAN, S., WHARTON, J., JANSEN, I., AND POLAK, J.: Peptide containing nerves in the rat femoral artery and vein: an immunocytochemical and vasomotor study. Blood Vessels 26: 254-271, 1989c.
61. EDVINSSON, L., HAKANSON, R., STEEN, S., SUNDJER, F., UDDMAN, R., AND WAHLESTEDT, C.: Innervation of human omental arteries and veins and vasomotor responses to noradrenaline, NPY, Substance P, and VIP. Regul. Pept. 12: 67-79, 1985b.
62. EDWARDS, R. M., STACK, E. J., AND TRIZNA, W.: CGRP stimulates adenylate cyclase and relaxes intracerebral arterioles. J. Pharmacol. Exp. Ther. 257: 1020-1024, 1991.
63. EDWARDS, R. M., AND TRIZNA, W.: CGRP: effects on renal arteriolar tone and tubular cyclic AMP levels. Am. J. Physiol. 258: F121F-F125, 1990.
64. EGUCHI, S., HIRATA, Y., KANO, H., SATO, K., WATANABE, Y., WATANABE, T. X., NAKAJIMA, K., SAKAKIBARA, S., AND MARUMO, F.: Specific receptors for adrenomedullan in cultured rat vascular smooth muscle cells. FEBS Lett. 340: 226-230, 1994.
65. ELHAWARY, A. M., AND PANG, C. C. Y.: Renal vascular and tubular actions of CGRP: effect of NG-Nitro L Arginine methyl ester. J. Pharmacol. Exper. Therap. 273: 56-63, 1995.
66. ESCOTT, K. J., BEATTIE, D. T., CONNOR, H. E., AND BRAIN, S. D.: Trigeminal ganglion stimulation increases facial skin blood flow in the rat: a major role for CGRP. Brain Res. 669: 93-99, 1995.
67. EUROPEAN CGRP IN SUBARACHNOID HAEMORRHAGE STUDY GROUP: Effect of CGRP in patients with delayed postoperative cerebral ischaemia after aneuroysmal subarachnoid haemorrhage. Lancet 339: 831-834, 1992.
68. FANCIULLACCI, M., ALESSANDRI, M., FIGINI, M., GEPPETTI, P., AND MICHELACCI, S.: Increase in plasma CGRP from extracerebral circulation during nitroglycerin induced cluster headache attack. Pain 60: 119-123, 1995.
69. FAWLKES, R., SHAW, N., BOSE, C., AND HUGHES, B.: Differential vasodilator profile of CGRP in porcine large and small diameter coronary artery rings. Eur. J. Pharmacol. 201: 143-149, 1991.
70. FISCHER, J. A., AND BORN W.: Novel peptides from the calcitonin gene: expression, receptors and biological function. Peptides 6: 2652-2671, 1985.
71. FISCHER, J. A., TOBLER, P. H., HENKE, H., AND TSCHOPP, F. A.: Salmon and human calcitonin like peptides coexist in human thyroid and brain. J. Clin. Endocrinol. Metab. 57: 1314-1316, 1983.
72. FISCUS, R. R.: CGRP inhibits proliferation of cultured bovine aortic smooth muscle cells-potential anti-atherogenic action of CGRP. (Abstract) FASEB J. 7: 791, 1993.
73. FISCUS, R. R., HAO, H., WANG, X., ARDEN, W. A., AND DIANA, J. N.: Nitroglycerin (exogenous N. O.) substitutes for endothelium-derived NO in potentiating vasorelaxations and cyclic AMP elevations induced by CGRP in rat aorta. Neuropeptides 26: 133-144, 1994.
74. FISHER, L. A., KIKKAWA, D. O., RIVIER, J. E., AMARA, S. G., EVANS, R. E., ROSENFELD, M. G., VALE, W. W., AND BROWN, M. R.: Stimulation of noradrenergic sympathetic outflow by CGRP. Nature (Lond.) 305: 534-536, 1983.
75. FISHER, R. A., ROBERTSON, S. M., AND OLSON, M. S.: Stimulation and homologous desensitisation of CGRP receptors in cultured beating rat heart cells. Endocrinology 123: 106-112, 1988.
76. FOORD, S. M., AND CRAIG, R. K.: Isolation and characterisation of a human CGRP receptor. Eur. J. Biochem. 170: 373-379, 1987.
77. FORSGREN, S., MORAVEC, M., AND MORAVEC, J.: Catecholamine-synthesizing enzymes and neuropeptides in rat heart epicardial ganglia; an immunohistochemical study. Histochem. J. 22: 667-676, 1990.
78. FRANCO-CERECEDA, A.: CGRP and human epicardial coronary arteries: presence, release and vasodilator effects. Br. J. Pharmacol. 102: 506-510, 1991.
79. FRANCO-CERECEDA, A., BENGTSSON, L., AND LUNDBERG, J. M.: Inotropic effects of CGRP, VIP, and somatostatin on the human right atrium in vitro. Eur. J. Pharmacol. 134: 69-76, 1987a.
80. FRANCO-CERECEDA, A., GENNARI, C., NAMI, R., AGNUSDEI, D., PERNOW, J., LUNDBERG, J. M., AND FISCHER, J. A.: Cardiovascular effects of CGRP I and II in man. Circ. Res. 60: 393-397, 1987b.
81. FRANCO-CERECEDA, A., HENKE, H., LUNDBERG, J. M., PETERMANN, J. B., HOKFELT, T., AND FISCHER, J. A.: CGRP in capsaicin-sensitive substance P-immunoreactive sensory neurones in animals and man- distribution and release by capsaicin. Peptides 8: 399-410, 1987c.
82. FRANCO-CERECEDA, A., KALLNER, G., AND LUNDBERG, J. M.: Cyclooxygenase products released by low pH have capsaicin-like actions on sensory nerves in the isolated guinea pig heart. Cardiovasc. Res. 28: 365-369, 1994.
83. FRANCO-CERECEDA, A., LOU, Y. P., AND LUNDBERG, J. M.: Ruthenium red inhibits CGRP release by capsaicin and resiniferatoxin but not by ouabain, bradykinin or nicotine in guinea pig heart: correlation with effects on cardiac contractility. Br. J. Pharmacol. 104: 305-310, 1991.
84. FRANCO-CERECEDA, A., AND LUNDBERG, J. M.: CGRP and capsaicin-induced stimulation of heart contractile rate and force. Naunyn Schmiedebergs Arch. Pharmacol. 331: 146-151, 1985.
85. FRANCO-CERECEDA, A., AND LUNDBERG, J. M.: Actions of CGRP and tachykinins in relation to the contractile effects of capsaicin in the guinea pig and rat heart in vitro. Naunyn Schmeidebergs Arch. Pharmacol. 337: 649-655, 1988.
86. FRANCO-CERECEDA, A., LUNDBERG, J. M., SARIA, A., SCHREIBMEYER, W., AND TRITTHART, H. A.: CGRP: release by capsaicin and prolongation of the action potential in the guinea pig heart. Acta Physiol. Scand. 132: 181-190, 1988.
87. FRANCO-CERECEDA, A., AND RUDEHILL, A.: Capsaicin-induced vasodilation of human coronary arteries in vitro is mediated by CGRP rather than substance P or neurokinin A. Acta Physiol. Scand. 136: 575-580, 1989.
88. FRANCO-CERECEDA, A., SARIA, A., AND LUNDBERG, J. M.: Ischaemia and changes in contractility induce release of CGRP but not NPY from isolated perfused guinea pig heart. Acta Physiol. Scand. 131: 319-320, 1987d.
89. FRANCO-CERECEDA, A., SARIA, A., AND LUNDBERG, J. M.: Differential release of CGRP and NPY from the isolated heart by capsaicin, ischaemia, nicotine, bradykinin and ouabain. Acta Physiol. Scand. 135: 173-187, 1989.
90. FUJIMORI, A., SAITO, A., KIMURA, S., WATANABE, T., UCHIYAMA, Y., KAWASAKI, H., AND GOTO, K.: Neurogenic vasodilation and release of CGRP from perivascular nerves in the rat mesenteric artery. Biochem. Biophys. Res. Commun. 164: 394-399, 1987.
91. FUKADA, F., AND FUMIJIWARA, M.: Effect of capsaicin on the guinea pig isolated atrium. J. Pharmacol. 21: 622-624, 1969.
92. FULLER, R. W., CONRADSON, T. B., DIXON, C. M. S., CROSSMAN, D. C., BARNES, P. J.: Sensory neuropeptide effects in human skin. Br. J. Pharmacol. 92: 781-788, 1987.
93. GALEAZZA, M. T., O'BRIEN, T. D., JOHNSTON, K. H., AND SEYBOLD, V. S.: IAPP competes for two binding sites of CGRP. Peptides 12: 585-591, 1991.
94. GARDINER, S. M., COMPTON, A. M., AND BENNETT, T.: Regional haemodynamic effects of CGRP. Am. J. Physiol. 256: R332-R338, 1989a.
95. GARDINER, S. M., COMPTON, A. M., AND BENNETT, T.: Regional haemodynamic effects of hα- and hβ-CGRP in conscious Wistar rats. Br. J. Pharmacol. 98: 1225-1232, 1989b.
96. 8-37 on regional haemodynamic actions of hα-CGRP. Biochem. Biophys. Res. Comm. 171: 938-943, 1991a.
97. GARDINER, S. M., COMPTON, A. M., KEMP, P. A., BENNETT, T., BOSE, C., FOULKES, R., AND HUGHES, B.: Antagonistic effect of hα-CGRP8-37 on regional haemodynamic actions of rat IAPP in conscious Long Evans rats. Diabetes. 40: 948-951, 1991a.
98. GARDINER, S. M., COMPTON, A. M., KEMP, P. A., BENNETT, T., FOULKES, R., AND HUGHES, B.: Regional haemodynamic effects of prolonged infusions of CGRP in conscious Long Evans rats. Br. J. Pharmacol. 103: 1509-1514, 1991b.
99. GARDINER, S. M., KEMP, P. A., MARCH, J. E., AND BENNETT, T.: Regional haemodynamic effects of human and rat adrenomedullin in conscious rats. Br. J. Pharmacol. 114: 584-591, 1995.
100. GENNARI, C., AND FISCHER, J. A.: Cardiovascular action of CGRP in humans. Calcif. Tissue. Int. 37: 581-584, 1985.
101. GENNARI, C., NAMI, R., AGNUSDEI, D., AND FISCHER, J. A.: Improved cardiac performance with human calcitonin gene-related peptide in patients with congestive heart failure. Cardiovasc. Res. 24: 239-241, 1990.
102. GIBBENS, I. L., FURNESS, J. B., COSTA, M., MACINTYRE, I., HILLYARD, C. J., AND GIRGIS, S.: Co-localisation of CGRP-like immunoreactivity with substance P-like immunoreactivity in cutaneous, vascular and visceral sensory neurones of guinea pigs. Neurosci. Lett. 57: 125-130, 1985.
103. GIBSON, S. J., POLAK, J. M., BLOOM, S. R., SABATE, I. M., MULDERRY, P. K., GHATEI, M. A., MCGREGOR, J. P., MORRISON, J. F. B., EVANS, R. M., AND ROSENFELD, M. G.: CGRP immunoreactivity in spinal cord of man and eight other species. J. Neurosci. 4: 3101-3111, 1984.
104. GILL, A. M., AND YEN, T. T.: Effects of ciglatazone on endogenous plasma IAPP and insulin sensitivity in obese-diabetic viable yellow mice. Life Sci. 48: 703-710, 1991.
105. GIRGIS, S. I., MACDONALD, D. W. R., STEVENSON, J. C., BEVIS, P. J. R., LYNCH, C., WIMALAWANSA, S. J., SELF, C. H., MORRIS, H. R., AND MACINTYRE, I.: CGRP-potent vasodilator and major product of calcitonin gene. Lancet 2: 14-16, 1985.
106. GIULIANI, S., WIMALAWANSA, S. J., AND MAGGI, C. A.: Involvement of multiple receptors in the biological effects of CGRP and amylin in rat and guinea pig preparations. Br. J. Pharmacol. 107: 510-514, 1992.
107. GOLTZMAN, D., AND MITCHELL, J.: Interaction of calcitonin and CGRP at receptor sites in target tissues. Science (Wash. DC) 222: 1343-1345, 1985.
108. GORMAN, R. R., BUNTING, S., AND MILLER, O. V.: Modulation of human platelet adenylate cyclase by prostacyclin. Prostaglandins 13: 377-388, 1977.
109. GOTO, K., ISHIKAWA, T., KIMURA, S., AND SAITO, A.: Role of CGRP as a cardiotonic neurotransmitter in guinea pig left atria. J. Pharmacol. Exp. Ther. 243: 723-730, 1987.
110. GOTO, K., MIYAUCHI, T., KONMA, S., AND OHISHIMA, N.: CGRP in the regulation of cardiac function. Ann. NY Acad. Sci. 657: 194-203, 1992.
111. GOTTLEIB, A., AND KOLTERMAN, O.: AC137, an amylin agonist: potent synthetic analog of human amylin containing proline substitutions at positions 25, 28 and 29 to limit self aggregation. (Abstract) Clin. Res. 42: 87, 1994.
112. GRACE, G. C., DUSTING, G. J., KEMP, B. E., AND MARTIN, T. J.: Endothelium and the vasodilator action of rat CGRP. Br. J. Pharmacol. 91: 729-733, 1987.
113. GRAY, D. W., AND MARSHALL, I.: Human α-CGRP stimulates adenylate cyclase and guanylate cyclase and relaxes rat thoracic aorta by releasing nitric oxide. Br J. Pharmacol. 107: 691-696, 1992a.
114. GRAY, D. W., AND MARSHALL, I.: NO synthesis inhibitors attenuate CGRP endothelium-dependent vasorelaxation in rat aorta. Eur. J. Pharmacol. 212: 37-42, 1992b.
115. GREENBERG, B., RHODEN, K., AND BARNES, P.: CGRP is a potent non- endothelium-dependent inhibitor of coronary vasomotor tone. Br. J. Pharmacol. 92: 789-794, 1987.
116. GREVES, P. L., NYBERG, F., HOKFELT, T., AND TERENIUS, L.: CGRP is metabolised by an endopeptidase hydrolizing substance P. Regul. Pept. 26: 277-286, 1989.
117. GRUNDITZ, T., EKMAN, R., HAKANSON, R., RERUP, C., AND UDDMAN, R.: CGRP in thyroid nerve fibres and C cells: effects on thyroid hormone secretion and response to hypercalcemia. Endocrinology 119: 2313-2324, 1986.
118. GULBENKIAN, S., EDVINSSON, L., OPGAARD, O. S., WHARTON, J., POLAK, J. M., AND DAVID-FERREIRA, J. F.: Peptide-containing nerve fibres in guinea pig coronary arteries: immunohistochemistry, ultrastructure and vasomotility. J. Auton. Nerv. Syst. 31: 153-168, 1990.
119. HAEGERSTRAND, A., DALSGAARD, C. J., JONZON, B., LARSSON, O., AND NILSSON, J.: CGRP stimulates proliferation of human endothelial cells. Proc. Natl. Acad. Sci. USA 87: 3299-3303, 1990.
120. 13-52 with CGRP receptors in the microvasculature of the rat and hamster. Br. J. Pharmacol. 114: 592-597, 1995.
121. HAN, S. P., NAES, L., AND WESTFALL, T. C.: CGRP is the endogenous mediator of Nanc vasodilation in rat mesentery. J. Pharmacol. Exper. Ther. 255: 423-428, 1990a.
122. 8-37 and CGRP receptor desensitization. Biochem. Biophys. Res. Comm. 168: 786-791, 1990b.
123. HANKO, J., HARDEBO, J. E., KAHRSTROM, J., OWMAN, C., AND SUNDLER, F.: CGRP is present in mammalian cardiovascular nerve fibres and dilates pial and peripheral arteries. Neurosci. Lett. 57: 91-95, 1985.
124. HAO, H., FISCUS, R. R., WANG, X., AND DIANA, J. N.: N-omega-Nitro-L-arginine inhibits vasodilations and elevations of both cyclic AMP and cyclic GMP levels in rat aorta induced by CGRP. Neuropeptides 26: 123-131, 1994.
125. HARTTER, E., SVOBODA, T., LUDVIK, B., SCHULLER, M., LELL, B., KUENBURG, E., BRUNNBAUER, M., WOLOSZCZUK, W., AND PRAGER, R.: Basal and stimulated plasma-levels of pancreatic amylin indicate its co- secretion with insulin in humans. Diabetologia 34: 52-54, 1991.
126. HELIN, K., TIKKANEN, I., KILARWRI, K., NAYERI, H., FYHRQUIST, F.: CGRP is not elevated in rat plasma by heart failure or by neutral endopeptidase inhibition. Life Sci. 55: 471-477, 1994.
127. HENDERSON, A. H., LEWIS, M. J., SHAH, A. M., AND SMITH, J. A.: Endocardium, endothelium and cardiac contraction. Cardiovasc. Res. 26: 305-308, 1992.
128. HENKE, H., SIGRIST, S., LANG, W., SCHNEIDER, J., AND FISCHER, J. A.: Comparison of binding sites for CGRP I and II in man. Brain Res. 410: 404-408, 1987.
129. HENKE, H., TSCHOPP, F. A., AND FISCHER, J. A.: Distinct binding sites for CGRP and sCT in rat central nervous system. Brain Res. 360: 165-171, 1985.
130. HIRATA, Y., TAKAGI, Y., TAKATA, S., FUKUDA, Y., YOSHIMI, H., AND FUJITA, T.: CGRP receptor in cultured vascular smooth muscle and endothelial cells. Biochem. Biophys. Res. Commun. 151: 1113-1121, 1988.
131. HOLLAND, J. P., SYDSERFF, S. G. C., TAYLOR, W. A. S., AND BELL, B. A.: CGRP reduces brain injury in a rat model of focal cerebral ischaemia. Stroke 25: 2055-2058, 1994.
132. HOLMAN, J. J., CRAIG, R. K., AND MARSHALL, I.: Human α- and β-CGRP and rat α-CGRP are coronary vasodilators in the rat. Peptides 7: 231-235, 1986.
133. HOLZER P.: Local effector functions of capsaicin-sensitive sensory nerve endings: involvement of tachykinins, CGRP and other neuropeptides. Neuroscience. 24: 739-768, 1988.
134. HOLZER, P., AND GUTH, P. H.: Neuropeptide control of rat gastric mucosal blood flow. Circ. Res. 68: 100-105, 1991.
135. HUGHES, S. R., AND BRAIN, S. D.: A CGRP antagonist, CGRP8-37, inhibits microvascular responses induced by CGRP and capsaicin in skin. Br. J. Pharmacol. 104: 738-742, 1991.
136. HULST, K. L., HACKENG, W. H. L., AND LIPS, C. J. M.: Improved method for determination of islet amyloid polypeptide levels in plasma. Ann. Clin. Biochem. 31: 165-170, 1994.
137. HUTTEMEIER, P. C., RITTER, E. F., AND BENVENISTE, H.: CGRP mediates hypotension and tachycardia in endotoxic rats. Am. J. Physiol. 265: H767-H769, 1993.
138. HVARFNER, A., BERGSTROM, R., MORLIN, C., THEODORSSON, E., AND JUNGHALLS, I.: CGRP response to intravenous calcium is related to blood pressure. Acta. Physiol. Scand. 132: 439-440, 1988.
139. ISHIKAWA, T., OKAMURA, N., SAITO, A., AND GOTO, K.: Effects of CGRP and isoproterenol on the contractility and adenylate cyclase activity in the rat heart. J. Mol. Cell. Cardiol. 19: 723-727, 1987.
140. ISHIKAWA, T., OKAMURA, N., SAITO, A., MASAKI, T., AND GOTO, K.: Positive inotropic effect of CGRP mediated by cyclic AMP in guinea pig heart. Circ. Res. 63: 731-736, 1988.
141. JAGER, K., MUENCH, R., SEIFERT, H., BEGLINGER, C., BOLLINGER, A., AND FISCHER, J. A.: CGRP causes redistribution of blood flow in humans. Eur. J. Clin. Pharmacol. 39: 491-494, 1990.
142. JANSEN, I.: Characterization of CGRP receptors in guinea pig basilar artery. Neuropeptides 21: 71-79, 1992.
143. JANSEN, I., MORTENSEN, A., AND EDVINSSON, L.: Characterization of CGRP receptors in human cerebral vessels: vasomotor responses and cyclic AMP accumulation. Ann. NY Acad. Sci. 657: 435-440, 1992.
144. JIAN, T., DONG, X., AND Q. I.-XIOA, Y.: CGRP in the pathogenesis and treatment of hypertension. Chinese Med. J. 102: 897-901, 1989.
145. JOHNSTON, F. G., BELL, B. A., AND ROBERTSON, I. J. A.: Post-operative neurological deficits after subarachnoid haemorrhage. Lancet 335: 869-872, 1990.
146. JONAS, V., LIN, C. R., AND KAWASHIMA, E.: Alternative RNA processing events in human calcitonin gene-related peptide gene expression. Proc. Natl. Acad. Sci. USA 82: 1994-1998, 1985.
147. JOYCE, C. D., FISCUS, R. R., WANG, X., DRIES, D. J., MORRIS, R. C., AND PRINZ, R. A.: CGRP levels are elevated in patients with sepsis. Surgery 108: 1097-1101, 1990a.
148. JOYCE, C. D., PRINZ, R. A., THOMAS, J. X., FISCUS, R. R., WANG, X., DJURICIN, G., AND JACOBS, H. K.: CGRP increases coronary flow and decreases coronary resistance. J. Surg. Res. 49: 435-440, 1990b.
149. KATAYAMA, M., NADEL, J. A., BUNNETT, N. W., MARIA, G. U., HAXHIU, M., AND BORSON, D. B.: Catabolism of CGRP and substance P by neutral endopeptidase. Peptides 12: 563-567, 1991.
150. KAUTZKY-WILLER A., AND THOMASETH K.: Role of IAPP secretion in insulin-resistant humans. Diabetalogia 37: 188-94, 1994.
151. KAWASAKI, H., NUKI, C., SAITO, A., AND TAKASAKI, K.: Adrenergic modulation of CGRP-containing nerve mediated vasodilation in the rat mesenteric resistance vessel. Brain Res. 506: 287-290, 1990a.
152. KAWASAKI, H., NUKI, C., SAITO, A., AND TAKASAKI, K.: Role of CGRP- containing nerves in the vascular adrenergic neurotransmission. J. Pharmacol. Exper. Therap. 252: 403-409, 1990b.
153. KAWASAKI, H., NUKI, C., SAITO, A., AND TAKASAKI, K.: NPY modulates neurotransmission of CGRP-containing vasodilator nerves in rat mesenteric arteries. Am. J. Physiol. 261: 683-690, 1991.
154. KAWASAKI, H., SAITO, A., AND TAKASAKI, K.: Age-related decrease of CGRP-containing vasodilator innervation in mesenteric resistance vessel of spontaneously hypertensive rat. Circ. Res. 67: 733-743, 1990c.
155. KAWASAKI, H., AND TAKASAKI K.: Age-related decrease of neurogenic release of CGRP from perivascular nerves in spontaneously hypertensive rats. Clin. Exper. Hyper. A14: 989-1001, 1992.
156. KAWASAKI, H., TAKASAKI, K., SAITO, A., AND GOTO, K.: CGRP is a novel vasodilator neurotransmitter in mesenteric resistance vessels of spontaneously hypertensive rat. Nature (Lond.) 335: 164-167, 1988.
157. KIM, C., ROBERTS, A. M., AND JOSHUA, I. G.: Differences in the capsaicin-induced dilation of arterioles and venules in rat striated muscle. J. Pharmacol. Exper. Therap. 273: 605-610, 1995.
158. + current in atrial cells. Eur. J. Physiol. 418: 338-345, 1991.
159. KITAMURA, K., KANGAWA, K., KAWAMOTO, M., ICHIKI, Y., NAKAMURA, S., MATSUO, H., AND ETO, T.: Adrenomedullin: a novel hypotensive peptide from human phaeochromacytoma. Biochem. Biophys. Res. Comm. 192: 553-560, 1993.
160. KITAZANO, T., HEISTAD, D. D., AND FARACI, F. M.: Role of ATP-sensitive potassium channels in CGRP-induced dilation of rat basilar artery in vivo. Am. J. Physiol. 265: H581-H585, 1993.
161. KJARTANSSON, J., AND DALSGAARD, C. J.: CGRP increases survival of ischaemic surgical flaps. Eur. J. Pharmacol. 142: 355-358, 1987.
162. KLINE, L., AND PANG, P.: CGRP relaxed rat tail artery helical strips in vitro in a calcium-dependent manner. Eur J. Pharmacol. 150: 233-238, 1988.
163. KNIGHT, K. R., LEPORE, D. A., RITZ, M., BHATTACHARYA, S., MARTIN, T. J., MORRISON, W. A., O'BRIEN, B. M., AND SHIRAI, T.: Infusions of a novel CGRP derivative at the time of reperfusion to salvage ischaemic rabbit skin flaps. Inter. J. Tissue. Res. 15: 185-193, 1993.
164. KRAENZLIN, M. E., CH'N, G. J. L. C., AND MULDERRY, P. K.: Infusion of a novel peptide, CGRP, in man. Regul. Pept. 10: 189-197, 1985.
165. KREUTTER, D. K., ORENA, S. J., TORCHIA, A. J., CONTILLO, L. G., ANDREWS, G. C., AND STEVENSON, R. W.: Amylin and CGRP induce insulin resistance via a receptor distinct from cyclic AMP-coupled CGRP receptor. Am. J. Physiol. 264: 606-613, 1993.
166. KRUEGAR, J. W., FORLETTI, D., AND WITTENBERG, B. A.: Uniform sarcomere shortening behaviour in isolated cardiac muscle cells. J. Gen. Physiol. 76: 587, 1980.
167. KUBOTA, M., MOSELEY, J. M., BUTERA, L., MACDONALD, P. S., AND MARTIN, T. J.: CGRP stimulates cyclic AMP formation in rat aortic smooth muscle cells. Biochem. Biphys. Res. Commun. 132: 88-94, 1985.
168. KURTZ, A., MUFF, R., BORN, W., LUNDBERG, J. M., MILLBERG, B. I., GRADINGER, M. P., UEHEINGER, D. E., WEILDMAN, P., HOKFELT, T., AND FISCHER, J. A.: CGRP is a stimulant of renin secretion. J. Clin. Invest. 87: 538-543, 1988.
169. KURTZ, A., SCHUREK, H. J., JELKMANN, W., MUFF, R., LIPP, H. P., HECKMANN, U., ECKARDT, K. U., SCHOLZ, U., FISCHER, J. A., AND BAUER, C.: Renal mesangium as a target for CGRP. Kidney Inter. 36: 222-227, 1989.
170. LAPPE, R. W., TODT, J. A., AND WENAT, R. L.: Regional vasodilatory actions of CGRP in conscious spontaneously hypertensive rats. Peptides 8: 747-749, 1987.
171. LAUFER, R., AND CHANGEUX, J. P.: CGRP and cyclic AMP stimulate PI turnover in skeletal muscle cells: interaction between two second messenger systems. J. Bio. Chem. 264: 2683-2689, 1989.
172. LEWIS, S. J., SHULKES, A., BODWORTH, B., AND JARROTT, B.: Regional brain concentrations of CGRP in spontaneously hypertensive and normotensive Wistar Kyoto rats. J. Hypertension 8: 315-319, 1990.
173. LUDMAN, P. F., MASERI, A., CLARK, P., AND DAVIES, G. J.: Effects of CGRP on normal and atheromatous vessels and on resistance vessels in the coronary circulation in humans. Circulation 84: 1993-2000, 1991.
174. LUNDBERG, J. A., HUA, X. Y., AND FREDHOLM, B.: Capsaicin-induced stimulation of the guinea pig atrium-involvement of a novel sensory transmitter or a direct action on myocytes. Eur. J. Physiol. 325: 176-182, 1984.
175. LUNDBERG, J. A., HUA, X., HOKFELT, T., AND FISCHER, J. A.: Co-existence of substance P and CGRP-like immunoreactivity in sensory nerves in relation to the cardiovascular and bronchoconstrictor effects of capsaicin. Eur J. Pharmacol. 108: 315-319, 1985.
176. MAGGI, C. A., PATACCHINI, R., PERRETTI, F., TRAMONTANA, M., MANZINI, S., GEPPETTI, P., AND SANTICIOLI, P.: Sensory nerves, vascular endothelium and neurogenic relaxation of guinea pig isolated pulmonary artery. Naunyn-Schiedeberg's Arch. Pharmacol. 342: 78-84, 1990.
177. MAIR, J., LECHLEITNER, P., AND LAINGLE, T.: Plasma CGRP in acute myocardial infarction. Lancet 335: 168 (letter), 1990.
178. MANTELLI, L., AMERINI, S., FILIPPI, S., AND LEDDA, F.: Positive inotropic effects of CGRP and isoprenaline: analogies and differences. Neuropeptides 23: 193-198, 1992.
179. MANZINI, S., PERRETTI, F., AND TRAMONTANA, M.: Neurochemical evidence for CGRP-like immunoreactivity (CGRP-Li) release from capsaicin-sensitive nerves in rat mesenteric arteries and veins. Gen. Pharmacol. 22: 275-278, 1991.
180. MARSHALL, I.: Comparison of the relaxant effect of human alpha and beta CGRP with sodium nitroprusside in human pial arteries. In Neurotransmission and Cerebrovascular Function, ed. by J. Seylaz and E. T. MacKenzie, vol. 1, Elsevier, Amsterdam, pp. 285-292, 1989.
181. MARSHALL, I.: Mechanism of vascular relaxation by CGRP. Ann. NY Acad. Sci. 657: 204-215, 1992.
182. MARSHALL, I., AL-KAZAWINI, S. J., HOLMAN, J. J., AND CRAIG, R. K.: Human and ratαCGRP but not calcitonin cause mesenteric vasodilation in rats. Eur. J. Pharmacol. 123: 217-222, 1986a.
183. MARSHALL, I., AL-KAZAWINI, S. J., HOLMAN, J. J., AND CRAIG, R. K.: CGRP is a potent vasodilator in human mesenteric vasculature. Br. J. Clin. Pharmacol. 26: 691-695, 1988.
184. MARSHALL, I., AL-KAZAWINI, S. J., ROBERTS, P. M., SHEPPERSON, N. B., ADAMS, M., AND CRAIG, R. K.: Cardiovascular effects of human and rat CGRP compared in the rat and other species. Eur. J. Pharmacol. 123: 207-216, 1986b.
185. MASUDA, A., SHIMAMOTO, K., MORI, Y., NAKAGAWA, M., URA, N., AND IMURA, O.: Plasma CGRP levels in patients with various hypertensive diseases. J. Hypertens. 10: 1499-1504, 1992.
186. MATON, P. N., PRADHAN, T., ZHOU, Z. C., GARDNER, J. D., AND JENSEN, R. T.: Activities of CGRP and related peptides at the CGRP receptor. Peptides 11: 485-489, 1990.
187. MCCULLOUGH, J., UDDMAN, R., KINGMAN, T. A., AND EDVINSSON, L.: CGRP: functional role in cerebrovascular regulation. Proc. Natl. Acad. Sci. USA 83: 5731-5735, 1986.
188. MCCORMACK, D. G., MAK, J. C. W., COUPE, M. O., AND BARNES, P. J.: CGRP vasodilation of human pulmonary vessels. J. Appl. Physiol. 67: 1265-1270, 1989.
189. MCEWAN, J., LARKIN, S., DAVIES, G., CHIERCHIA, S., BROWN, M., STEVENSON, J., MACINTYRE, I., AND MASERI, A.: CGRP: a potent dilator of human epicardial coronary arteries. Circulation 74: 1243-1247, 1986.
190. MCEWAN, J. R., RITTER, J. M., AND MCDERMOTT, J.: CGRP activates adenylate cyclase of bovine aortic endothelial cells: GTP dependance and partial agonist activity of a tyrosinated analogue. Cardiovasc. Res. 23: 921-927, 1989a.
191. MCEWAN, J., LEGON, S., WIMALAWANSA, S., ZAIDI, M., DOLLERY, C., AND MACINTYRE, I.: CGRP: a review of its biology and relevance to the cardiovascular system. In Perspectives in Hypertension, ed. by J. H. Laragh, B. M. Brenner and N. M. Kaplan, pp. 287-306, Raven Press, New York, 1989b.
192. MCHUGH, N. J., CSUKA, M., WATSON, H., BELCHER, G., AMADI, A., RING, E. F. J., BLACK, C. M., AND MADDISON, P. J.: Infusion of iloprost, a prostacyclin analog, for treatment of Raynaud's Phenomenon in systemic sclerosis. Annal. Rheumat. Dis. 47: 43-47, 1988.
193. MEJIA, J. A., PERNOW, J., VON HOLST, H., RUDEHILL, A., AND LUNDBERG, J. M.: Effects of neuropeptide Y, CGRP, Substance P and capsaicin on cerebral arteries in man and animals. J. Neurosurg. 69: 913-918, 1988.
194. MEYER, R., WEIMER, J., DEMBSKI, J., AND HAAS, H. G.: Photoelectric recording of mechanical responses of cardiac myocytes. Pflugers Arch. 408: 390-394, 1987.
195. MICHELANGELI, V. P., FINFLAY, D. M., FLETCHER, A., AND MARTIN, T. J.: CGRP acts independently of calcitonin on cyclic AMP formation in clonal osteogenic sarcoma cells (UMR 106 01). Calcif. Tissue Int. 39: 44-48, 1986.
196. MIMEAULT, M., FOURNIER, A., DUMONT, Y., ST.-PIERRE, S., AND QUIRION, R.: Comparative affinities and antagonistic potencies of various human CGRP fragments on CGRP receptors in brain and periphery. J. Pharmacol. Exp. Ther. 258: 1084-1090, 1991.
197. MIYAUCHI, T., SANO, Y., HIROSHIMA, O., YUZURIHA, T., SUGISHITA, Y., ISHIKAWA, T., SAITO, A., AND GOTO, K.: Positive inotropic effects and receptors of CGRP in porcine ventricular muscles. Biochem. Biophys. Res. Comm. 155: 289-294, 1988.
198. MOLNAR, J., GYORGY, L., UNYL, G., AND KENYERES, J.: The effect of capsaicin on the isolated guinea pig ileum and auricle. Acta. Physiol. Acad. Sci. Hung. 35: 369-374, 1969.
199. MORA, M., MARCHI, M., POLAK, J. M., GIBSON, S. J., AND CORNELIO, F.: CGRP immunoreactivity at the human neuromuscular junction. Brain. Res. 492: 404-407, 1989.
200. MORRIS, H. R., PANICO, M., ETIENNE, T., TIPPENS, J., GIRGIS, S. I., AND MACINTYRE I.: Isolation and characterisation of human CGRP. Nature (Lond.), 208: 746-748, 1984.
201. MULDER, H., LINDH, A. C., EKBLAD, E., WESTERMARK, P., SUNDLER, F.: IAPP is expressed in endocrine cells of the gastric mucosa in the rat and mouse. Gastroenterology 107: 712-719, 1994.
202. MULDERRY, P. K., GHATEI, M. A., BISHOP, A. E., ALLEN, J. S., POLAK, J. M., AND BLOOM, S. R.: Distribution and chromatographic characterization of CGRP-like immunoreactivity in brain and gut of the rat. Regul. Pept. 12: 133-143, 1985a.
203. MULDERRY, P. K., GHATEI, M. A., RODRIGO, J., ALLEN, J. M., ROSENFELD, M. G., POLAK, J. M., AND BLOOM, S. R.: CGRP in cardiovascular tissues of the rat. Neuroscience 14: 947-954, 1985b.
204. MULDERRY, P. K., GHATEI, M. A., AND SPOKES, R. A.: Differential expression of alpha-CGRP and Beta-CGRP by primary sensory neurones and enteric autonomic neurons of the rat. Neuroscience 25: 195-205, 1988.
205. MURAKAMI, T., AND YASUIDA, H.: Rat heart contains three substrates for cholera toxin catalysed ADP-ribosylation and a single substrate for pertussis toxin catalysed ADP-ribosylation. Biochem. Biophys. Res. Comm. 138: 1355-1361, 1986.
206. MYRDAL, U., LEPPERT, J., EDVINSSON, L., EKMAN, R., HEDNER, T., NILSSON, H., RINGQVIST, I.: CGRP is not elevated significantly in patients with primary Raynaud's Phenomenon. Clin. Physiol. 14: 539-546, 1994.
207. NAKAJIMA, T., TAKIKAWA, R., SUGIMOTO, T., AND KURACHI, Y.: Effects of CGRP on membrane currents in mammalian cardiac myocytes. Eur. J. Physiol. 419: 644-650, 1991.
208. NAKAMATA, H., FUKADA, Y., KOIDA, M., FUJII, N., OTAKA, A., FUNAKOSHI, S., YAMITA, H., MITSUYASU, N., AND ORLOWSKI, R. C.: Binding sites for CGRP: abundant occurrence in visceral organs. Jpn. J. Pharmacol. 42: 175-180, 1986.
209. NAKAZOTO, M., ASAI, J., KANGAWA, K., MATSUKURA, S., AND MATSUO, H.: Establishment of a radioimmunoassay for human islet amyloid polypeptide and its tissue content and plasma concentration. Biochem. Biophys. Res. Comm. 164: 394-399, 1989.
210. + channels. Nature (Lond.) 344: 770-773, 1990.
211. NILSSON, L., EDVINSSON, L., AND JANSEN, I.: Mechanisms of action of the dilatory response to CGRP in guinea pig basilar artery. Ann. NY Acad. Sci. 657: 510-512, 1992.
212. NUKI, C., KAWASAKI, H., KITAMURA, K., TAKENAGA, M., KANGAWA, K., ETO, T., AND WADA A.: Vasodilator effect of adrenomedullin and CGRP receptors in rat mesenteric vascular beds. Biochem. Biophys. Res. Comm. 196: 245-251, 1993.
213. NUKI, C., KAWASAKI, H., TAKASAKI, K., AND WADA, A.: Pharmacological characterization of presynaptic CGRP receptors on CGRP-containing vasodilator nerves in rat mesenteric resistence vessels. J. Pharmacol. Exper. Therap. 268: 59-64, 1994.
214. ODER-CEDERLOEF, I., THEODORSSON, E., ERIKSSON, C. G., AND KJELLSTRAND, C. M.: Plasma concentrations of CGRP increase during haemodialysis: relation to blood pressure. J. Intern. Med. 226: 177-182, 1989.
215. OHTSUKA, H., IWANGA, T., FUJINO, M. A., FUJITA, T.: Amylin-containing cells in the gastro-enteropancreatic endocrine system of the rat and humans - an immunohistochemical study. Acta Histochem. Cytochem. 26: 405-414, 1993.
216. ONO, K., DELAY, M., NAKAJIMA, T., IRISAWA, H., AND GILES, W.: CGRP regulates calcium current in heart muscle. Nature (Lond.) 340: 721-724, 1989.
217. ONO, K., AND GILES, W. R.: Electrophysiological effects of CGRP in bullfrog and guinea pig atrial myocytes. J. Physiol. 436: 195-217, 1991.
218. OPGAARD, O. S., GULBENKIAN, S., BERGDAHL, A., BARROSO, C. P., ANDRADE, N. C., POLAK, J. M., QUERROZEMELO, J., AND EDVINSSON, L.: Innervation of human epicardial coronary veins: immunohistochemistry and vasomotility. Cardiovasc. Res. 29: 463-468, 1995.
219. OSBORNE, N. N., AND BARNETT, N. L.: CGRP stimulates cyclic AMP production in the iris/ciliary body complex. Exp. Eye Res. 53: 131-133, 1991.
220. OWJI, A. A., SMITH, D. M., COPPOCK, H. A., MORGAN, D. G., BHOGAL, R., GHATEI, M. A., AND BLOOM, S. R.: An abundant and specific binding site for the novel vasodilator adrenomedullan in the rat. Endocrinology 136: 2127-2134, 1995.
221. PAPKA, R. E., FURNESS, J. B., DELLA, N. G., AND COSTA, M.: Depletion by capsaicin of substance P immunoreactivity and acetylcholinesterase activity from nerve fibres in the guinea pig heart. Neurosci. Lett. 27: 47-53, 1981.
222. PEREZ-CANO, R., GIRGIS, S. I., AND MACINTYRE, I.: Further evidence for calcitonin gene duplication: the identification of two different calcitonins in a fish, a reptide and two mammals. Acta Endocrinol. 100: 256-261, 1982.
223. PERNOW, J.: Actions of constrictor (NPY and endothelin) and dilator (Substance P, CGRP and VIP) peptides on pig splenic and human skeletal muscle arteries: involvement of the endothelium. Br. J. Pharmacol. 97: 983-989, 1989.
224. PERSSON, K., GARCIA-PASCUAL, A., AND ANDERSON, K. E.: Differences in the actions of CGRP on pig detrusor and vesical arterial smooth muscle. Acta Physiol. Scand. 143: 45-53, 1991.
225. PETERMANN, J. B., BORN, W., CHANG, J. Y., AND FISCHER, J. A.: Identification in the human central nervous system, pituitary and thyroid of a novel CGRP and partial amino-acid sequence in the spinal cord. J. Bio. Chem. 262: 542-545, 1987.
226. PIPER, H. M., MILLAR, B. C., AND MCDERMOTT, B. J.: The negative inotropic effect of neuropeptide Y on the ventricular cardiomyocyte. Naunyn-Schmiedebergs Arch. Pharmacol. 340: 333-337, 1989.
227. POPESCU, L. M., PANOIU, C., HINESCU, M., AND NUTO, O.: The mechanism of cyclic GMP-induced relaxation in vascular smooth muscle. Eur. J. Pharmacol. 107: 393-394, 1985.
228. POPPER, P., AND MICEVYCH, P. E.: Localization of CGRP and its receptors in a striated muscle. Brain Res. 496: 180-186, 1989.
229. PORTALUPPI, F., VERGNANI, L., MARGUTTI, A., AMBROSIO, M. R., BONDANELLI, M., TRANSFORINI, G., ROSSI, R., AND UBERTI, E. C. D.: Modulatory effect of the renin-angiotensin system on the plasma levels of CGRP in normal man. J. Clin. Endocrinol. Metab. 77: 816-820, 1993.
230. POWELL, T., FERRAR, D. A., AND TWIST, V. W.: Electrical properties of individual myocytes isolated from the adult rat ventricular myocardium. J. Physiol. 302: 131, 1980.
231. PREIBISZ, J. J.: CGRP and regulation of human cardiovascular homeostasis. Am. J. Hypertension. 6: 434-450, 1993.
232. PRIETO, D., BENEDITO, S., AND NYBORG, N. C. B.: Heterogeneous involvement of endothelium in CGRP-induced relaxation in coronary arteries from rat. Br. J. Pharmacol. 103: 1764-1768, 1991.
233. QUEBBEMAN, B. B., DULAS, D., ALTMAN, J., HOMANS, D. C., AND BACHE, R. J.: Effect of CGRP on well-developed canine coronary collateral vasculature. J. Cardiovasc. Pharmacol. 21: 774-780, 1993.
234. 2 receptor subtypes. Ann. NY Acad. Sci. 657: 88-91, 1992.
235. RANGNEKAR, V. R., FIGUEIRDO, H. F., CARLSON, S., AND MCGILLIS, J. P.: CGRP enhances IL-1 induced neutrophil adhesion to endothelial cells by increasing expression of ELAM-1 (E-selectin). FASEB J. 8: 235 (Abstract), 1994.
236. RECHARDT, L., AALTO-SETALA, K., PURJERANTA, M., PELTO-HUIKKO, M., AND KYOSOLA, K.: Peptidergic innervation of the human atrial myocardium: an electron microscopic and immunocytochemical study. J. Auton. Nerv. Syst. 17: 21-32, 1986.
237. REN, Y. S., MA, T. G., WANG, H. B., AND Y. U. S. Q.: Protective effects of CGRP on myocardial cell injury and calcium and magnesium contents following severe hypoxia and simulated reperfusion. Med. Sci. Res. 21: 177-178, 1993.
238. RESNICK, L. M.: Calcitropic hormones in human and experimental hypertension. In Endocrine Mechanisms in Hypertension, ed. by J. H. Laragh and B. A. Brenner, Raven Press, New York, pp. 265-86, 1989.
239. RESNICK, L. M., PREBISZ, J. J., AND LARAGH, J. H.: CGRP-like immunoreactivity in hypertension: relation to blood pressure, sodium and calcium metabolism. In Salt and Hypertension, ed. by D. Ganten and E. Ritz, Springer Verlag, Berlin, pp. 190-199, 1989.
240. RIGEL, D. F.: Effects of neuropeptides on heart rate in dogs: comparison of VIP, PHI, NPY, CGRP and NT. Am. J. Physiol. 255: 311-317, 1988.
241. RIGEL, D. F., GRUPP, I. L., BALASUBRAMANIAM, A., AND GRUPP, G.: Contractile effects of cardiac neuropeptides in isolated canine atrial and ventricular muscles. Am. J. Physiol. 257: H1082-H1087, 1988.
242. RINK, T. J., BEAUMONT, K., KODA, J., AND YOUNG, A.: Structure and Biology of Amylin. TIPS 14: 113-118, 1993.
243. ROSENFELD, M. G., MERMOD, J. J., AMARA, S. G., SWANSON, L. W., SAWCHENKO, P. E., RIVIER, J., VALE, W. W., AND EVANS, R. M.: Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing. Nature (Lond.) 304: 129-135, 1983.
244. 19-37. Peptides 13: 1025-1027, 1992.
245. SAITO, A., ISHIKAWA, T., KIMURA, S., AND GOTO, K.: Role of CGRP as a cardiotonic neurotransmitter in guinea pig left atria. J. Pharmacol. Exp. Ther. 243: 731-736, 1987.
246. SAITO, A., KIMURA, S., AND GOTO, K.: CGRP as potential neurotransmitter in guinea pig right atrium. Am. J. Physiol. 250: H693-H698, 1986.
247. SAITO, A., MASAKI, T., UCHIYAMA, Y., LEE, T. J. F., AND GOTO, K.: CGRP and vasodilator nerves in large cerebral arteries of cats. J. Pharmacol. Exp. Ther. 248: 455-462, 1989.
248. SAKURADA, T., LE GREVES, P., AND TERENIUS, L.: Fragmentation of CGRP and Substance P in the rat central nervous system. Neurochem. Int. 19: 341-347, 1991.
249. SAMUELSON, U. E., AND JERNBECK, J.: CGRP relaxes porcine arteries via one endothelium-dependent and one endothelium-independent mechanism. Acta Physiol. Scand. 141: 281-282, 1991.
250. SANO, Y., HIROSHIMA, O., YUZURICHA, C., YAMATO, C., SAITO, A., KIMURA, S., HIRABAYASHI, T., AND GOTO, K.: CGRP binding sites of porcine cardiac muscles and coronary arteries: solubilization and characterization. J. Neurochem. 52: 1919-1924, 1988.
251. SARIA, A., GUMSE, R., PETERMANN, J., FISCHER J. A., NORHEIM, E., AND LUNDBERG, J. M.: Simultaneous release of several tachykinins and CGRP from rat spinal cord slices. Neurosci. Lett. 63: 310-312, 1986.
252. SATOH, H., DELAY-GOYET, P., AND LUNDBERG, J. M.: Involvement of tachykinin and CGRP receptors in the cardiopulmonary effects evoked by capsaicin in the guinea pig. Regul. Pept. 46: 297-299, 1993.
253. SATOH, M., OKU, R., MAEDA, A., FUJII, N., OTAKA, A., FUNAKOSHI, S., YAJIMA, H., AND TAKAGI, H.: Possible mechanisms of positive inotropic action of synthetic human CGRP in isolated rat atrium. Peptides 7: 631-635, 1986.
254. SCHIFTER, S.: Circulating concentrations of CGRP in normal man determined with a new, highly sensitive radioimmunoassay. Peptides 12: 365-369, 1989.
255. SCHIFTER, S., KRUSSELL, L. R., AND SCHESTED, J.: Normal serum levels of CGRP in mild to moderate essential hypertension. Am. J. Hypertens. 4: 565-569, 1991.
256. SCHINI-KERTH, V. B., FISSLTHALER, B., AND BUSSE, R.: CGRP enhances induction of NO synthase in vascular smooth muscle cells via a cyclic AMP-dependent mechanism. Am. J. Physiol. 267: H2483-H2490, 1994.
257. SEIFERT, H., SAWCHENKO, P., CHESNUT, J., RIVIER, J., VALE, W., AND PANDOL, S. J.: Receptor for CGRP: binding to exocrine pancreas mediates biological actions. Am. J. Physiol. 249: G147-G151, 1985.
258. SEITZ, P. K., AND COOPER, C. W.: Calcitonin, CGRP and renal calcitonin receptors in the Zucker rat. Bone Miner. 2: 53-62, 1987.
259. SELF, C. H., WIMALAWANSA, S. J., JOHANSSON, A., BATES, D., GIRGIS, S. I., AND MACINTYRE, I.: A new sensitive and fast peptide immunoassay based on enzyme amplification used in the determination of CGRP and the demonstration of its presence in the thyroid. Peptides 6: 627-630, 1985.
260. SEXTON, P. M., MCKENZIE, J. S., AND MENDLESOHN, F. A. O.: Evidence for a new subclass of CT/CGRP binding sites in rat brain. Neurochem. Int. 12: 323-335, 1988.
261. SHEKAR, Y. C., ANAND, I. S., AND SARMA, R.: Effects of prolonged hαCGRP on the haemodynamics, renal blood flow and hormone levels in congestive heart failure. Am. J. Cardiol. 67: 732-736, 1991.
262. SHIMOSEGAWA, T., AND SAID, S. I.: Co-occurrence of immunoreactive calcitonin and CGRP in neuroendocrine cells of rat lungs. Cell Tissue Res. 264: 555-561, 1991.
263. SHOJI, T., ISHIHARA, T., SAITO, A., AND GOTO, K.: Vasodilating effects of human and rat CGRP in isolated porcine coronary arteries. Eur. J. Physiol. 336: 438-444, 1987.
264. SHULKES, A.: CGRP: potential role in vascular disorders. Drugs Aging 3: 189-194, 1993.
265. SIGRIST, S., FRANCO-CERECEDA, A., MUFF, R., HENKE, H., LUNDBERG, J. M., AND FISCHER, J. A.: Specific receptor and cardiovascular effects of CGRP. Endocrinology 119: 381-389, 1986.
266. SIGRIST S,. A., BORN, W., AND FISCHER, J. A.: Identification of a receptor for CGRP I and II in human cerebellum. Biochem. Biophys. Res. Comm. 151: 1081-1087; 1988.
267. SILVESTRE, R. A., DEGANO, P., SALAS, M., PEIRO, E., AND MARCO, J.: Reversal of the inhibitory effects of CGRP and amylin on insulin secretion by the 8-37 fragment of human CGRP. Biochem. Pharmacol. 45: 2343-2347, 1993.
268. SMITH, J. A., SHAH, A. M., AND LEWIS, M. J.: Factors released from the endocardium of the ferret and pig modulate myocardial contraction. J. Physiol. 439: 1-14, 1991.
269. SPOKES, R. A., KANSE, S., MULDERRY, P. K., AND BLOOM, S. R.: Membrane binding and biological activity of rat CGRPα and CGRPβ: evidence for one class of high affinity receptor. Regul. Pept. 18: 365, 1987.
270. STEENBERGH, P. H., HOPPENER, J. W. M., ZANDBERG, J., LIPS, C. J. M., AND JANSZ, H. S.: A second human calcitonin/CGRP gene. FEBS Lett. 183: 403-407, 1985.
271. STEENBERGH, P. H., HOPPENER, J. W. M., ZANDBERG, J., VISSER, A., LIPS, C. J. M., AND JANSZ, H. S.: Structure and expression of the human calcitonin/ CGRP genes. FEBS Lett. 209: 97-103, 1986.
272. STEVENSON, J. C., MACDONALD, D. W. R., WARREN, R. C., BOOKER, M. W., AND WHITEHEAD, M. J.: Increased concentration of circulating CGRP during normal human pregnancy. B. Med. J. 293: 1329-1330, 1986.
273. STRUTHERS, A. D., BROWN, M. J., MACDONALD, D. W. R., BEACHAM, J. L., STEVENSON, J. C., MORRIS, H. R., AND MACINTYRE, I.: Human CGRP: a potent endogenous vasodilator in man. Clin. Sci. 70: 389-393, 1986.
274. SUGIYAMA, A., KOBAYASHI, M., TSUJIMOTO, G., MOTOMURA, S., AND HASIMOTO, K.: The first demonstration of CGRP-immunoreactive fibres in canine hearts: coronary vasodilator, inotropic and chronotropic effects of CGRP in canine isolated blood-perfused heart preparations. Jpn. J. Pharmacol. 50: 421-427, 1989.
275. SUN, B., DAVENPORT, A. P., AND BROWN, M. J.: Quantitative autoradiography reveals higher densities of specific CGRP receptors in small intramyocardial compared with large epicardial coronary arteries. Clin. Sci. 84: 55-60, 1993.
276. SUPOWIT, S. C., RAMANA, C. V., WESTLUND, K. N., AND DIPETTE, D. J.: CGRP gene expression in the spontaneously hypertensive rat. Hypertension 21: 1010-1014, 1993.
277. SUTTER, B., SUZUKI, S., KASSELL, N. F., AND LEE, K. S.: Characteristics of relaxation induced by CGRP in contracted rabbit basilar artery. J. Neurosurg. 83: 91-96, 1995.
278. TAKAMI, K., HASHIMOTO, K., UCHIDA, S., TOHYAMA, M., AND YOSHIDA, H.: Effect of CGRP on the cyclic AMP level of isolated mouse diaphragm. Jap. J. Pharmacol. 42: 345-350, 1986.
279. TAKAMI, K., KAWAI, Y., UCHIDA, S., TOHYAMA, M., SHIOTANI, Y., YOSHIDA, H., EMSON, P. C., GIRGIS, S., HILLYARD, J., AND MACINTYRE, I.: Effect of CGRP on contraction of striated muscle in the mouse. Neurosci. Lett. 60: 227-230, 1985.
280. TANG, J., XU, D., YUAN, O. X., MENG, Z. H., CHEN, F. R., AND CHEN, M. Z.: CGRP in the treatment and pathogenesis of hypertension. Chin. Med. J. 102: 897-901, 1989.
281. TENNEY, S. M.: CGRP mechanism of vasorelaxation. (Note) News Physiol. Sci., 5: 272, 1990.
282. THOM, S. M. J., HUGHES, A. D., GOLDBERG, P., MARTIN, T. J., SCHACKLER, M., AND SEVERS, P. S.: The actions of CGRP and VIP as vasodilators in man in vivo and in vitro. Br. J. Clin. Pharmacol. 24: 129-134, 1987.
283. TIPPENS, J. R., GREENWALD, S. E., LEVER, M. J., MACINTYRE, I., AND MORRIS, H. R.: Coronary vasodilation induced by CGRP in the anaesthetised pig. Neuropeptides 13: 95-102, 1988.
284. TODA, N., USUI, H., NISHIMO, N., AND FUJIVARA, M.: Cardiovascular effects of capsaicin in dogs and rabbits. J. Pharmacol. Exp. Ther. 181: 512, 1972.
285. TRAMONTANA, M., GIULLIANI, S., BIANCO, E. D., LECCI, A., MAGGI, C. A., EVANGELISTRA, S., AND GEPPETTI, P.: Effects of capsaicin and 5HT3 antagonists on 5HT-evoked release of CGRP in the guinea pig heart. Br. J. Pharmacol. 108: 431-435, 1993.
286. TRANSFORINI, G., MARGUTTI, A., PORTALUPPI, F., MENEGATTI, M., AMBROSIO, M. R., BAGNI, B., PANSINI, R., AND UBERTI, E. C. D.: Orcadian profile of plasma CGRP in healthy man. J. Clin. Endocrinol. Metab. 73: 945-951, 1991.
287. TRANSFORINI, G., MARGUTTI, A., VERGNANI, L., AMBROSIO, M. R., VALENTINI, A., ROSSI, R., PORTALUPPI, F., AND UBERTI, E. C. D.: Evidence that enhancement of cholinergic tone increases basal plasma levels of CGRP in normal man. J. Clin. Endocrinol. Metab. 78: 763-766, 1994.
288. TSCHOPP, F. A., HENKE, H., PETERMANN, J. B., TOBLER, P. H., JANZER, R., HOKFELT, T., LUNDBERG, J. M., CUELLO, C., AND FISCHER, J. A.: CGRP and its binding sites in the human central nervous system and pituitary. Proc. Natl. Acad. Sci. USA 82: 248-252, 1985.
289. TUNG, L.: An ultrasensitive transucer for measurement of isometric contractile force from single heart cells. Pflugers Arch. 407: 109-115, 1986.
290. UCHIDA, S., YAMAMOTO, H., ITO, S., MATSUMOTO, N., WANG, X. B., YONEHARA, N., IMAI, Y., INOKI, R., AND YOSHIDA, H.: Release of CGRP-like immunoreactive substance from neuromuscular junction by nerve excitation and its action on striated muscle. J. Neurochem. 54: 1000-1003, 1890.
291. UDDMAN, R., AND EDVINSSON, L.: Neuropeptides in the cerebral circulation. Cerebrovasc. Brain Metab. Rev. 1: 230-252, 1989.
292. UDDMAN, R., EDVINSSON, L., EKBALD, E., HAKANSON, R., AND SUNDLER, F.: CGRP: perivascular distribution and vasodilatory effects. Regul. Pept. 15: 1-23, 1986.
293. UDDMAN, R., EDVINSSON, L., EKMAN, R., KINGMAN, T., AND MCCULLOUGH, J.: Innervation of the feline cerebral vasculature by nerve fibres containing CGRP: trigeminal origin and co-existence with Substance P. Neurosci. Lett. 82: 131-136, 1985.
294. UREN, N. J., SEYDOUX, C., AND DAVIES, G. J.: Effect of intravenous infusion of CGRP on ischaemia threshold and coronary stenosis severity in humans. Cardiovasc. Res. 27: 1477-1481, 1993.
295. URSELL, P. C., REN, C. L., ALBALA, A., AND DANILO, P.: Nonadrenergic noncholinergic innervation: anatomic distribution of CGRP-immunoreactive tissue in the dog heart. Circ. Res. 68: 131-140, 1991a.
296. URSELL, P. C., REN, C. L., AND DANILO, P.: Anatomic distribution of autonomic neural tissue in the developing dog heart. Anat. Rec. 230: 531-538, 1991b.
297. VALDERMARSSON, S., EDVINSSON, L., HEDNER, P., AND EKMAN, R.: Hormonal influence on CGRP in man: effect of sex difference and contraceptive pills. Scand. J. Clin. Lab. Invest. 50: 385-388, 1990.
298. VAN JAARSVELD, B. C., HACKENG, W. H. L., AND LIPS, C. J. M.: Plasma concentrations of IAPP after glucagon administration in type 2 diabetic patients and non-diabetic patients. Diabetic Med. 10: 327-330, 1993.
299. VAN ROSSUM, D., MENARD, D. P., FOURNIER, A., ST. PIERRE, S., AND QUIRION, P.: Autoradiographical distribution and receptor binding profile of 1251-Bolton Hunter rat amylin binding in rat brain. J. Pharmacol. Exper. Therap. 270: 779-787, 1994.
300. VANVALEN, F., PIECHOT, G., AND JURGENS, H.: CGRP receptors are linked to cyclic AMP production in Sk-N-MC human neuroblastoma cells. Neurosci. Lett. 119: 195-198, 1990.
301. VERBURG, K. M., FREEMAN, R. H., VILLARREAL, D., AND BRANDS, M. W.: Cardiovascular and renal effects of CGRP in hypotensive dogs. Peptides 10: 663-669, 1989.
302. VILLARREAL, D., FREEMAN, R. H., VERBURG, K. M., AND BRANDS, M. W.: Renal haemodynamic response to intrathecal infusion of CGRP in dogs. Peptides 9: 1129-1135, 1988a.
303. VILIARREAL, D., FREEMAN, R. H., VERBURG, K. M., AND BRANDS, M. W.: Effects of CGRP on renal blood flow in the rat. Proc. Soc. Exp. Biol. Med. 188: 316-322, 1988b.
304. WANG, X., AND FISCUS, R. R.: CGRP increases cyclic AMP, tension, and rate in rat atria. Am. J. Physiol. 256: R421-R428, 1989.
305. WANG, X., HAN, C., AND FISCUS, R. R.: CGRP causes endothelium-dependent cyclic AMP, cyclic GMP and vasorelaxant responses in rat abdominal aorta. Neuropeptides 20: 115-124, 1991.
306. WANG, X., HAN, C. D., FISCUS, R. R., QI. M., AND JONES, S. B.: Hypertension-induced and endotoxin-induced alterations in CGRP: modulation by dexamethasone. Circ. Shock 34: 217-223, 1991a.
307. WANG, X., HAN, C., YANG, L., CHEN, M., AND FISCUS, R. R.: Ibuprofen, indomethacin, and high aspirin, but not low-dose aspirin or imadazole inhibit CGRP elevations in plasma during endotoxicosis. Ann. NY Acad. Sci. 657: 502- 504, 1992.
308. WANG, X., JONES, S. B., AND ZHOU, Z.: CGRP levels in plasma are greatly elevated during endotoxic shock in the rat. Circ. Shock 24: 242-244, 1988.
309. WANG, X., JONES, S. B., ZHOU, Z., HAN, C., AND FISCUS, R. R.: CGRP and NPY levels are elevated in plasma and decreased in vena cava during endotoxin shock in the rat. Circ. Shock 36: 21-30, 1992a.
310. WARBANOW, W., AND WOLLENBERGER, A.: Time parameters of contraction of inotropically responding cultured heart cells in relation to cellular cyclic AMP levels. Life Sci. 31: 1603-1612, 1982.
311. WEBBER, S. E., LIM, J. C. S., AND WIDDICOMBE, J. G.: The effects of CGRP on submucosal gland secretion and epithelial albumin transport in the ferret trachea in vitro. Br. J. Pharmacol. 102: 79-84, 1991.
312. WESTFALL, T. C., HAN, S. P., KNUEPFER, M., MARTIN, J., CHEN, X., DEL VALLE, K., CIARLEGLIO, A., AND NAES, L.: Neuropeptides in hypertension; role of NPY and CGRP. Br. J. Clin. Pharmacol. 30: 75S-80S, 1990.
313. WHARTON, J., AND GULBENKIAN, S.: Peptides in the mammalian cardiovascular system. Experimentia 43: 821-832, 1987.
314. WHARTON, J., GULBENKIAN, S., MULDERRY, P. K., GHATEI, M. A., MCGRESOR, G. P., BLOOM, S. R., AND POLAK, J. M.: Capsaicin induces a depletion of CGRP immunoreactive nerves in the cardiovascular system of the guinea pig and rat. J. Auton. Nerv. Syst. 16: 289-309, 1986.
315. WIENCKE, A. K., NIELSEN, P. J., AND NYBORG, N. C. B.: NANC vasodilation in bovine intraocular anterior ciliary artery involves CGRP and nitric oxide. Invest. Opthal. Visual. Sci. 34: 826, 1993.
316. WIMALAWANSA, S. J.: Effects of in vivo stimulation on molecular forms of circulating calcitonin and CGRP in man. Ann. NY Acad. Sci. 657: 77-86, 1990.
317. WIMALAWANSA, S. J.: Circadian variation of plasma CGRP in man. J. Neuroendocrinol. 3: 319-321, 1991.
318. WIMALAWANSA, S. J.: The effects of neonatal capsaicin on plasma levels and tissue contents of CGRP. Peptides 14: 247-252, 1993.
319. WIMALAWANSA, S. J., EMSON, P. C., AND MACINTYRE, I.: Regional distribution of CGRP and its specific binding sites in rats with particular reference to the nervous system. Neuroendocrinology 46: 131-136, 1987.
320. WIMALAWANSA, S. J., GUNASEKERA, R. D., AND ZHANG, F.: Isolation, purification and characterization of CGRP. Peptides 14: 691-699, 1993.
321. WIMALAWANSA, S. J., AND MACINYTRE, I.: CGRP and its specific binding sites in the cardiovascular system of rat. Int. J. Cardiol. 20: 29-37, 1988.
322. WIMALAWANSA, S. J., MORRIS, H. R., ETIENNE, A., BLENCH, I., PANICO, M., AND MACINTYRE, I.: Isolation, purification and characterisation of β- hCGRP from human spinal cord. Biochem. Biophys. Res. Commun. 167: 993-1000, 1990.
323. WOHLWEND, A. M., MALMESTROM, K., HENKE, H., MURER, H., VASSALLI, J. D., AND FISCHER, J. A.: Calcitonin and CGRP interact with the same receptor in cultured LLC-PKI kidney cells. Biochem. Biophys. Res. Comm. 131: 537-542, 1985.
324. YAMAGUCHI, A., CHIBA, T., OKIMURA, Y., YAMATANI, T., MORISHITA, T., NAKAMURA, A., INUI, T., NODA, T., AND FUJITA, T.: Receptors for CGRP on the rat liver plasma membranes. Biochem. Biophys. Res. Comm. 152: 383-391, 1988.
325. YAOITA, H., SATA, E., KAWAGUCHI, M., SAITO, T., MAEHARA, K., AND MARUYAMA, Y.: NANC nerves regulate basal coronary flow via release of capsaicin-sensitive neuropeptides in rat heart. Circ. Res. 75: 780-788, 1994.
326. YOSHIZAKI, H., TAKAMIYA, M., AND OKADA, T.: Characterization of picomolar affinity binding sites for CGRP in rat brain and heart. Biochem. Biophys. Res. Comm. 146: 443-451, 1987.
327. YOUNG, A. A., GEDULIN, B., GRETA, LSL, PRICKETT, K. S., BEAUMONT, K., LARSON, E., AND RINK, T. J.: Selective amylin antagonist suppresses rise in plasma lactate after intravenous glucose in rat: evidence for a metabolic role of endogenous amylin. FEBS Lett. 343: 237-241, 1994.
328. YOUNG, A. A., RiNK, T. J., AND WANG, M. W.: Dose-response characteristics for the hyperglycaemic, hyperlactemic, hypotensive and hypocalcemic actions of amylin and CGRP-I (CGRPα) in the fasted, anaesthetized rat. Life Sci. 52: 1717-1726, 1993.
329. ZAIDI, M., AND BEVIS, P. J. R.: Enhanced circulating levels of neurally derived CGRP in spontaneously hypertensive rats. Cardiovasc. Res. 25: 125-128, 1991.
330. ZAIDI, M., BEVIS, P. J. R., ABEYASEKERA, G., GIRGIS, S. I., WIMALAWANSA, S. J., MORRIS, H. R., AND MACINTYRE, I.: The origin of circulating CGRP in the rat. J. Endocrinol. 110: 185-190, 1986.
331. ZAIDI, M., BEVIS, P. J. R., GIRGIS, S. I., LYNCH, C., STEVENSON, J. C., AND MACINTYRE, I.: Circulating CGRP comes from the perivascular nerves. Eur. J. Pharmacol. 117: 283-284, 1985.
332. ZAIDI, M., BREIMER, L. H., AND MACINTYRE, I.: Biology of peptides from the calcitonin genes. Q. J. Exp. Physiol. 72: 371-408, 1987.
333. ZHANG, J. F., JIN, L., LIU, X. Z., LIU, M. Y., SHENG, S. L., AND ZHANG, W. J.: The effect of CGRP on ischaemic reperfusion-induced arrhythmias in rats. Inter. J. Cardiol. 46: 33-36, 1994.
334. ZHU, G., DUDLEY, D. T., AND SALTIEL, A. R.: Amylin increases cyclic AMP formation in L6 myocytes through CGRP receptors. Biochem. Biophys. Res. Comm. 177: 771-776, 1991.
335. ZSCHAUER, A., UUSITALO, H., AND BRAYDEN, J. E.: Characteristics of CGRP-induced relaxation in rabbit opthalmic artery. Ann. NY Acad. Sci. 657: 507-509, 1991.
336. ZSCHAUER, A., UUSITALO, H., AND BRAYDEN, J. E.: Role of endothelium and hyperpolarization in C. G. R.P-induced vasodilation of rabbit opthalmic artery. Am. J. Physiol. 283: H359-H365, 1992.